Shares of Dynatronics (NASDAQ:DYNT) fell 1.5% in pre-market trading after the company reported Q1 results.
Earnings per share fell 300.00% year over year to ($0.04), which beat the estimate of ($0.12).
Revenue of $12,133,000 decreased by 25.97% year over year, which beat the estimate of $10,550,000.
Earnings guidance hasn't been issued by the company for now.
Dynatronics hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Nov 12, 2020
Time: 08:30 AM
ET Webcast URL: https://irdirect.net/DYNT/corporate_document/1982
Company's 52-week high was at $3.70
Company's 52-week low was at $0.52
Price action over last quarter: down 21.61%
Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.